These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24681838)

  • 1. Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
    Savage EM; Millar AM; Taggart AJ
    Rheumatology (Oxford); 2014 Jun; 53(6):1154-5. PubMed ID: 24681838
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: reply.
    Glaspole I; Hoy R; Ryan P
    Rheumatology (Oxford); 2014 Jun; 53(6):1155. PubMed ID: 24681841
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
    Glaspole IN; Hoy RF; Ryan PF
    Rheumatology (Oxford); 2013 Dec; 52(12):2302-4. PubMed ID: 23661426
    [No Abstract]   [Full Text] [Related]  

  • 4. Interstitial lung disease following certolizumab pegol.
    Pearce F; Johnson SR; Courtney P
    Rheumatology (Oxford); 2012 Mar; 51(3):578-80. PubMed ID: 22116998
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe interstitial lung disease following treatment with certolizumab pegol: a case report.
    Lager J; Hilberg O; Løkke A; Bendstrup E
    Eur Respir Rev; 2013 Sep; 22(129):414-6. PubMed ID: 23997067
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal fibrosing alveolitis with certolizumab.
    Millar A; McKew J; Taggart A
    Rheumatology (Oxford); 2012 May; 51(5):953-5. PubMed ID: 22328567
    [No Abstract]   [Full Text] [Related]  

  • 7. Blaschkitis under certolizumab for rheumatoid arthritis.
    Couderc M; Soubrier M
    Joint Bone Spine; 2014 Jul; 81(4):372-3. PubMed ID: 24439961
    [No Abstract]   [Full Text] [Related]  

  • 8. How FABulous is PEGgy? Certoliziumab pegol from the bench to the patients.
    Aletaha D
    BioDrugs; 2014 Apr; 28 Suppl 1():S3-4. PubMed ID: 24687233
    [No Abstract]   [Full Text] [Related]  

  • 9. [Certolizumab pegol].
    Delgado Frías E; Díaz González JF
    Reumatol Clin; 2011 Mar; 6S3():S7-11. PubMed ID: 21794764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab for rheumatoid arthritis.
    Markatseli TE; Papagoras C; Nikoli A; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2014; 32(3):415-23. PubMed ID: 24447441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug safety evaluation of certolizumab pegol.
    Ferrante M; Vermeire S; Rutgeerts PJ
    Expert Opin Drug Saf; 2014 Feb; 13(2):255-66. PubMed ID: 24156537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL; Valesini G
    BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced erythema nodosum after the administration of certolizumab in Crohn's disease.
    Biedermann L; Kerl K; Rogler G; Hofbauer GF
    Inflamm Bowel Dis; 2013 Jan; 19(1):E4-6. PubMed ID: 22127817
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological agents in monotherapy for the treatment of rheumatoid arthritis.
    Gabay C; Hasler P; Kyburz D; So A; Villiger P; von Kempis J; Walker U
    Swiss Med Wkly; 2014; 144():w13950. PubMed ID: 24723273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease.
    Majumder S; Kumar A
    J Crohns Colitis; 2013 Feb; 7(1):e19. PubMed ID: 22742971
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.
    Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Iwai K; Sakamaki Y; van der Heijde D; Miyasaka N; Koike T
    Mod Rheumatol; 2014 Jul; 24(4):552-60. PubMed ID: 24981319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol.
    Pasut G
    BioDrugs; 2014 Apr; 28 Suppl 1():S15-23. PubMed ID: 24687235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.
    Fleischmann R
    Expert Opin Biol Ther; 2010 May; 10(5):773-86. PubMed ID: 20230188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.